Looking back on an extraordinary year, we are pleased with how much practical support Eastern AHSN was the East of England, despite the pressures of the two waves of Covid-19 and the months spent under lockdown. We have also deepened our collaborations with our partners in the health and life sciences industries, leveraging their direct support to the NHS and supporting the introduction of their innovative products and solutions. the rollout of telephone, online and digital consultation in primary care within just a few weeks. This included distributing 3 million worth of hardware, including safe virtual consultations frontline duties for a while, and we supported an extensive rollout of remote technology to more than 200 care homes in the region to enable them to monitor residents vital signs. This helped managers to know when it was safe to care for residents in the home setting and when GP or emergency medical resources were needed. In the autumn, we also supported the wide roll-out of home oximeters to people across the East of England, contributing to a virtual ward arrangement where people with Covid-19 could self-monitor to check whether they needed an emergency hospital admission, facilitating safe discharge earlier. We also supported the recruitment of volunteers to assist in the vaccine roll-out across the East of England. Much has been written about how, in the face of the service and technology transformation in a period of just a few weeks that would normally have taken many years. Innovative Technology-driven service change will be essential in helping the NHS to address the long wait lists technologies were adopted at pace because of the need to manage infection risk, but in many cases these technologies have saved valuable clinician and patient time and the need for administrative support that could be better that technology-driven service change will be essential in helping the NHS to address the long wait lists and potential unmet need that has built up in non-Covid illness over the past year. We are also mindful excluded communities in a more targeted way. Improvement to showcase innovative ways of looking after patients in our region during the pandemic, with notable examples being the virtual orthopaedic rehab clinics run in Cambridgeshire and Peterborough and innovative Covid Protect (22,894) of the target group and triggered over 12,000 calls to action for support. Finally, we are delighted with the successes achieved by our partners in our longer-term collaborations. EarlyCDT Lung, a simple blood test to detect autoantibodies associated with lung cancer that can be done in primary care in high-risk populations. It has 277 people for triage into CT scanning support the adoption of four innovations in cardiac and primary care. Both these achievements were facilitated by our new innovation managers hosted by the ICS, and we hope to further these arrangements next year. Our Health Data Research Hub Gut Reaction has passed its second milestone and secured substantial We are in awe of the expertise, energy and dedication of our community in responding to the pandemic commercial support, and we secured two new collaborations with the pharmaceutical industry that will support investigations into persistent depression and the education of specialist nurses in lysosomal disease. Piers continued to chair the AHSN Network throughout the year (you can read about our collective achievements on the AHSN Network website) and we are grateful to the senior management team at Eastern AHSN for stepping up to enable team at NHS Test and Trace over the summer and autumn. He was part of the team that secured funding for the development of new lab-based and mobile testing technologies and supported the expansion of We are in awe of the expertise, energy and dedication of our community in responding to the pandemic and successes over the past year that you can read about in this review. Piers Ricketts Elisabeth Buggins Chief Executive Chair